Additionally, the association between elevated circulating CDC42 levels and adverse clinical outcomes underscores its potential as a prognostic marker in CRC (169, 170), emphasizing its importance in both cancer biology and immune regulation. Here, CDC42 is linked to colorectal carcinoma.